14-day Premium Trial Subscription Sign Up For FreeGet Free

Abeona Therapeutics Inc. Stock Forecast NASDAQ:ABEO

Price Target and Analyst Ratings

Most Recent Rating

On July 19, 2021 "HC Wainwright" gave "$8.00 - $5.00" rating for ABEO. The price target was changed from $1.28 to 5.2%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-07-19 $8.00 - $5.00 Target Lowered by HC Wainwright $1.23 $1.28→5.2%
2021-04-14 Buy Reiterated by HC Wainwright $1.60 $8.00
2021-03-29 Buy Reiterated by SVB Leerink $1.79
2021-02-16 Outperform Reiterated by SVB Leerink $2.72
2021-02-16 Buy Reiterated by HC Wainwright $2.72 $8.00
2020-11-25 Buy Target Lowered by HC Wainwright $1.41 $11.00 → $8.00
2020-11-25 Buy Reiterated by HC Wainwright $1.41 $11.00 → $8.00
2020-11-11 Buy Reiterated by B. Riley $1.30 $2.00 → $3.00
2020-11-10 Neutral - Overweight Upgraded by Cantor Fitzgerald $1.15
2020-11-10 Outperform Target Lowered by SVB Leerink $1.15 $8.00 → $5.00
2020-10-06 Buy Reiterated by B. Riley $1.22 $2.00
2020-07-13 Buy Reiterated by HC Wainwright $2.86 $11.00
2020-05-08 Outperform Target Lowered by Royal Bank of Canada $2.69 $11.00 → $7.00

ABEO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -23.66% during the next 3 months and, with a 90% probability hold a price between $0.77 and $1.01 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $1.00 $1.16 $1.32
2021-09-21 $0.99 $1.15 $1.31
2021-09-22 $0.99 $1.15 $1.31
2021-09-23 $0.98 $1.14 $1.30
2021-09-24 $0.97 $1.13 $1.29
2021-09-27 $0.97 $1.13 $1.29
2021-09-28 $0.96 $1.12 $1.28
2021-09-29 $0.95 $1.11 $1.27
2021-09-30 $0.95 $1.11 $1.27
2021-10-01 $0.94 $1.10 $1.26
2021-10-04 $0.93 $1.09 $1.25
2021-10-05 $0.93 $1.09 $1.25
2021-10-06 $0.92 $1.08 $1.24
2021-10-07 $0.92 $1.07 $1.23
2021-10-08 $0.91 $1.07 $1.23
2021-10-11 $0.90 $1.06 $1.22
2021-10-12 $0.90 $1.05 $1.21
2021-10-13 $0.89 $1.05 $1.21
2021-10-14 $0.88 $1.04 $1.20
2021-10-15 $0.88 $1.04 $1.19
2021-10-18 $0.87 $1.03 $1.19
2021-10-19 $0.86 $1.02 $1.18
2021-10-20 $0.86 $1.02 $1.17
2021-10-21 $0.85 $1.01 $1.17
2021-10-22 $0.84 $1.00 $1.16
2021-10-25 $0.84 $1.00 $1.16
2021-10-26 $0.83 $0.99 $1.15
2021-10-27 $0.82 $0.98 $1.14
2021-10-28 $0.82 $0.98 $1.14
2021-10-29 $0.81 $0.97 $1.13

About Abeona Therapeutics Inc.

Abeona Therapeutics Abeona Therapeutics Inc. focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs are ABO-101 (AAV NAGLU) and ABO-102 (AAV SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). It is also developing ABO-201 (AAV CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV FANCC) for Fanconi anemi... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT